Unichem Laboratories Ltd.

NSE: UNICHEMLAB | BSE: 506690 | ISIN: INE351A01035 | Industry: Pharmaceuticals
| Falling Comet
574.1000 -15.70 (-2.66%)
NSE Jun 18, 2025 15:31 PM
Volume: 46,917
 

574.10
-2.66%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 20% YoY to | 368 crore (I-direct estimate: | 366 crore) on account of 20% YoY growth in domestic formulations to | 227 crore (I-direct estimate: | 228 crore) and 26% growth in export formulations to | 113 crore (I-direct estimate: | 111 crore) EBITDA margins declined 51 bps YoY to 10.8% (I-direct estimate: 14.0%) due to higher other expenditure and employee cost despite improvement in gross margins. EBITDA increased 15% YoY to | 40...
Unichem Laboratories Ltd. has lost -26.51% in the last 6 Months
More from Unichem Laboratories Ltd.
Recommended